APA Zitierstil

Verreault, M., Schmitt, C., Goldwirt, L., Pelton, K., Haidar, S., Levasseur, C., . . . Idbaih, A. (2015). Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2 amplified and TP53 wild-type glioblastomas. Clin Cancer Res.

Chicago Zitierstil

Verreault, Maite, et al. "Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2 Amplified and TP53 Wild-type Glioblastomas." Clin Cancer Res 2015.

MLA Zitierstil

Verreault, Maite, et al. "Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2 Amplified and TP53 Wild-type Glioblastomas." Clin Cancer Res 2015.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.